Stocks / NASDAQ / Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.

Our Opinion

Protagonist Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their medical products and clinical research.

Supporting Evidence:

Report that specifies that the company conducts animal testing

“PTG-100, an oral peptide antagonist of integrin α4β7 that alters trafficking of gut homing T cells in preclinical animal models”

Company Description

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which offers proprietary peptide technology platform, which discovers and develops new chemical entities to address significant unmet medical needs. [Source: MarketWatch]

Company Website: